title: Cost-benefit analysis of hepatitis-B vaccination.
abstract: Since 1983 the Belgian insurance Fund for Occupational Disease (FOD) has refunded the cost of hepatitis-B (HB) vaccination. Vaccination has been carried out by occupational physicians selectively on staff in hospitals and medical-care institutions. At the end of 1986, 40,000 people at high risk of HBV infection had been vaccinated. The vaccination costs are largely offset by the benefits resulting from the striking fall in the number of HB cases. The financial investment has proved economically beneficial for the insurance fund.
mesh_terms: D001530:Belgium; D003362:Cost-Benefit Analysis; D005069:Evaluation Studies as Topic; D005260:Female; D006509:Hepatitis B / Q000191:economics / Q000517:prevention & control; D017325:Hepatitis B Vaccines; D006801:Humans; D007348:Insurance, Health; D008297:Male; D008505:Medical Staff, Hospital; D009784:Occupational Diseases / Q000191:economics / Q000517:prevention & control; D012306:Risk; D014611:Vaccination / Q000191:economics*; D014761:Viral Hepatitis Vaccines
chemical_list: D017325:Hepatitis B Vaccines; D014761:Viral Hepatitis Vaccines